Immunome Appoints Dr. Dennis Giesing as Chief Development Officer
Immunome Appoints Dr. Dennis Giesing as Chief Development Officer
– Pharmaceutical industry veteran brings more than three decades of experience developing innovative therapies –
Comments are closed.